Similarly, other in vitro and vivo studies showed that in both estrogen receptor negative breast cancer cells and in MCF-7 xenograft models, OLE reduced the expression of NF-κB by regulating its cascade activation, leading to tumor cell apoptosis [29,30]. Here, NFKB1 is linked to breast carcinoma.